After Demand Climbed With COVID-19, Abbott Expects Continued Nutritional Line Sales Growth
Post-Pandemic OTC Diagnostics Sales Also Look Promising To Firm
Executive Summary
CEO Robert Ford says “dynamics” of more consumers fortifying their diets to promote immunity from COVID-19 “are driving strong growth for our Ensure and Glucerna brands.” Analysts don't share Ford's confidence, though, for continued OTC diagnostics sales growth.